alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
_____________________________________

Page is not included in this copy.

Pages 215 through 217 are not included in this

copy.

_______________________________________________________________

The material not included contains the following type of
information:

_____ Identity of product inert ingredients.

_____ Identity of product impurities.

_____ Description of the product manufacturing process.

_____ Description of quality control procedures.

_____ Identity of the source of product ingredients.

_____ Sales or other commercial/financial information.

_____ A draft product label.

__X___ The product confidential statement of formula.

_____ Information about a pending registration action.

_____ FIFRA registration data.

_____ The document is a duplicate of page(s) _______.

_____ The document is not responsive to the request.

_____ Proprietary information pertaining to the chemical composition of an inert ingredient provided by the source of the ingredient.

_____ Attorney-Client Privilege.

_____ Claimed Confidential by submitter upon submission to the

Agency.

_____ Internal Deliberative Information.

* The information not included is generally considered confidential by product registrants. If you have any questions, please contact the individual who prepared the response to your request.
No. 11-5177.

#### Robert M. Hendricks, et ux., Petitioners v. Robert Stepp, et al.

565 U.S. 1046, 132 S. Ct. 606,

181 L. Ed. 2d 444,

2011 U.S. LEXIS 8081.

November 14, 2011.

Petition for rehearing denied.

Former decision, 565 U.S. 893, 132 S. Ct. 278, 181 L. Ed. 2d 165, 2011 U.S. LEXIS 5503.
ex10a.htm
















Exhibit 10(a)

















Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm












We consent to the reference to our firm under the caption “Independent Registered Public Accounting Firm” in Post-Effective Amendment No. 11 to the Registration Statement (Form N-4 No. 333-141759) pertaining to Lincoln New York Account N for Variable Annuities, which is incorporated by reference into Post-Effective Amendment No. 13, and to the use therein of our reports dated (a) March 30, 2012, with respect to the financial statements of Lincoln Life & Annuity Company of New York and (b) March 30, 2012, with respect to the financial statements of Lincoln New York Account N for Variable Annuities.







/s/ Ernst & Young LLP







Philadelphia, Pennsylvania


March 30, 2012
[Federal Register Volume 63, Number 147 (Friday, July 31, 1998)]
[Notices]
[Page 40898]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20477]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. PR98-11-000]


PanEnergy Louisiana Intrastate Pipeline Company; Notice of 
Informal Settlement Conference

July 27, 1998.
    Take notice that an informal settlement conference in the above-
captioned proceeding will be held on Thursday, July 30, 1998, at 10:00 
A.M. in a room to be designated at the offices of the Federal Energy 
Regulatory Commission, 888 First Street, N.E., Washington, D.C.
    Participation will be limited to the parties and staff. For 
additional information, please contact Louis Lieb at (202) 208-0012.
David P. Boergers,
Acting Secretary.
[FR Doc. 98-20477 Filed 7-30-98; 8:45 am]
BILLING CODE 6717-01-M
Health Care Provider Role :15

You Can Help Your Patients Quit Smoking

The spot opens with the U.S. Surgeon General Dr. Jerome Adams speaking to the camera. The CDC logo 

appears. A name card appears which reads: “Dr. Jerome Adams, U.S. Surgeon General”

DR. JEROME ADAMS: I’m U.S. Surgeon General, Dr. Jerome Adams. If you have patients who smoke, 

you play a critical role in helping them quit. 

The spot cuts to footage of a counselor’s office. A female counselor speaks with a male patient and 

shows him an informational handout. We see close ups of counselor writing on the handout with a pen 

and then close ups of the counselor’s face and the patient’s face as they continue to talk. 

DR. JEROME ADAMS: Providing your patients with a combination of counseling and medication can 

increase their chances to quit smoking. 

The spot cuts back to Dr. Jerome Adams speaking to the camera.

DR. JEROME ADAMS: Advise your patients to quit and connect them to treatment that can help them 

quit for good. Ask, advise, connect. It’s that simple. 

ART CARD: Learn how to help your patients quit at www.surgeongeneral.gov

Logos for the U.S. Department of Health and Human Services, the Centers for Disease Control and 

Prevention, and the U.S. Public Health Service appear on screen.
CALENDAR YEAR 2023

 MPA SCHEDULE OF SUBMISSION AND 

EFFECTIVE DATES 

SUBMISSION DATE

10 JANUARY 23

14 FEBRUARY 23

14 MARCH 23

11 APRIL 23

09 MAY 23

13 JUNE 23

11 JULY 23

08 AUGUST 23

12 SEPTEMBER 23

10 OCTOBER 23 08 

14 NOVEMBER 23

12 DECEMBER 23

EFFECTIVE/VALIDITY DATE

05 FEBRUARY 23

05 MARCH 23

02 APRIL 23

07 MAY 23

04 JUNE 23

02 JULY 23

06 AUGUST 23

03 SEPTEMBER 23

01 OCTOBER 23

05 NOVEMBER 23

03 DECEMBER 23

07 JANUARY 24
(1) Adjusting Price $24.98 CWT

(2) Base Price $23.74 CWT

(3) Change from Base Price per CWT $1.24

(4) Price change per gallon $0.11

(Line (3) divide by 11.63 gallons/cwt)

(5) Price change per half gallon $0.05

Price change per quart $0.03 

Price change per pint $0.01

Price change per 14-oz pg. $0.01

Price change per 12-oz pg. $0.01

Price change per 1/3 qt. (10-oz) $0.01

Price change per half pint $0.01

(6) Price adjustment per gallon $0.11

Price adjustment per half gallon $0.05

Price adjustment per quart $0.03

Price adjustment per pint $0.01

Price change per 14-oz pg. $0.01

Price change per 12-oz pg. $0.01

Price adjustment per 1/3 qt. (10-oz) $0.01

Price adjustment per half pint $0.01

NOTE: Numbers in brackets are negative or decreases, all others are positive or increases.

Monthly EPA Calculation for Class I Milk (Clause 52.216-9032 Alt. I)

Based on California Marketing Area Federal Milk Order #51

 Effective Date: Mar. 6th, 2022
I 

116TH CONGRESS 

1ST SESSION H. R. 3404 

To amend the National Firearms Act to require that local chief law enforcement officers be notified of, and provided a 90-day period to deny, 

firearm transfers. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 21, 2019 

Ms. WEXTON (for herself, Mr. BEYER, Mr. CONNOLLY, Ms. NORTON, Mr. 

NEGUSE, Ms. CLARK of Massachusetts, Mr. CICILLINE, and Mr. 

CISNEROS) introduced the following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the National Firearms Act to require that local 

chief law enforcement officers be notified of, and provided a 90-day period to deny, firearm transfers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Empowering Law En5 forcement for Safer Firearm Transfers Act of 2019’’. 


pbinns on DSK79D2C42PROD with BILLS
2 

•HR 3404 IH

1 SEC. 2. NOTIFICATION OF LOCAL CHIEF LAW ENFORCE2 MENT OFFICER IN CASE OF FIREARM TRANS3 FER. 

4 (a) IN GENERAL.—Section 5812 of the Internal Rev5 enue Code of 1986 is amended by striking ‘‘; and (6)’’ 

6 and inserting ‘‘(6) the Secretary has notified the chief law 

7 enforcement officer of the jurisdiction in which the trans8 feree primarily resides that such application is pending, 

9 and such officer either (A) certifies that there is no objec10 tion to the transfer, or (B) does not, before the end of 

11 the 90-day period beginning on the date of such notifica12 tion, certify to the Secretary that (i) the transferee poses 

13 a danger to the transferee or others, or (ii) there is a rea14 sonable likelihood the transferee will use the firearm for 

15 unlawful purposes; and (7)’’. 

16 (b) EFFECTIVE DATE.—The amendment made by 

17 this section shall apply with respect to applications filed 

18 after the date of the enactment of this Act. 

Æ 


pbinns on DSK79D2C42PROD with BILLS
EXHIBIT
32.2




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of theglobe.com, inc. (the "Company") on
Form 10-Q for the period ending June 30, 2009, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Edward A. Cespedes,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
to the best of my knowledge and belief:





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.


Dated:
      July 31, 2009
                  By:
                  /s/ 
      Edward A.
      CespedesEdward
      A. CespedesChief
      Financial
Officer
(1) Adjusting Price $18.44 CWT

(2) Base Price $17.48 CWT

(3) Change from Base Price per CWT $0.96

(4) Price change per gallon $0.0825

(Line (3) divide by 11.63 gallons/cwt)

(5) Price change per half gallon $0.0413

Price change per quart $0.0206

Price change per pint $0.0103

Price change per 12-oz pg. $0.0077

Price change per 1/3 qt. (10-oz) $0.0064

Price change per half pint $0.0052

(6) Price adjustment per gallon $0.08

Price adjustment per half gallon $0.04

Price adjustment per quart $0.02

Price adjustment per pint $0.01

Price change per 12-oz pg. $0.01

Price adjustment per 1/3 qt. (10-oz) $0.01

Price adjustment per half pint $0.01

NOTE: Numbers in brackets are negative or decreases, all others are positive or increases.

Monthly EPA Calculation for Class I Milk (Clause 52.216-9032 Alt. I)

Based on California Dept. of Food and Agriculture Announcement of Minimum Prices

 Effective Date: July 5, 2015
**Exhibit 32.2**

**STATEMENT OF CHIEF FINANCIAL OFFICER UNDER 18 U.S.C. § 1350**

I, Eric Smit, the chief financialofficer of eGain Communications Corporation (the “Company”), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to my knowledge, 

(i) the Quarterly Report of the Company on Form 10-Q for the period ending September 30, 2007 (the “Report”), fully complies with therequirements of section 13(a) of the Securities Exchange Act of 1934, and 

(ii) the information contained in the Report fairly presents, inall material respects, the financial condition and results of operations of the Company. 

 

A signed original of this written statement required by 18 U.S.C. § 1350 has been provided to eGainCommunications Corporation and will be retained by eGain Communications Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
No. 11-6546.

#### Clifton Shields, Petitioner v. United States.

565 U.S. 991, 132 S. Ct. 531,

181 L. Ed. 2d 372,

2011 U.S. LEXIS 7617.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

*373Same case below, 415 Fed. Appx. 437.
No. 11-6369.

#### Juan Gonzalez, Petitioner v. United States.

565 U.S. 969, 132 S. Ct. 468,

181 L. Ed. 2d 305,

2011 U.S. LEXIS 7593.

October 17, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.

Same case below, 429 Fed. Appx. 909.
If you’re a person with a disability or are using assistive technology and are having difficulty accessing any of the content in this file, please contact dmi@cdc.gov.

CDC Data Modernization Initiative | A Roadmap of Activities and Expected Outcomes

ACTIVITIES

If we (CDC and partners) do this ...

SHORT-TERM

OUTCOMES

... then we expect these changes to occur ...

INTERMEDIATE

OUTCOMES

... which will lead to ...

LONG -TERM

OUTCOMES

... our ultimate goals.

COORDINATE PEOPLE

AND SYSTEMS

Create interoperable systems:

federal, state, local, and healthcare 

Coordinate investments, decisions,

and policies across CDC and

with partners 

Make data sharing easier through

common policies, practices,

and standards 

Advance academic and private

partnerships 

Increased collaboration, communication, and messaging among CDC 

and partners 

Reduced data collection and

reporting burden at state, tribal, local,

and territorial levels 

Improved data sharing and interoperability through common standards

like HL7® FHIR®

Increased capacity to quickly analyze, 

interpret, and act on data 

Effective coordination on complex 

health and emergency response

challenges

Timely and complete data reporting

to CDC 

Efficient, secure data access and 

exchange between systems across 

the country 

A more comprehensive picture to 

improve decision-making and protect 

health for all 

CDC can rapidly identify 

and effectively mitigate

emerging threats

Trusted data promotes

evidence-based behaviors,

interventions, and solutions

to protect health

ACCELERATE DATA 

FOR ACTION

Identify data for priority public 

health needs 

Upgrade and modernize IT infrastructure 

Strengthen the data science workforce

Adopt open standards and tools

while protecting data security

Translate data into evidence-based

recommendations

Increased electronic reporting and 

specific enhancements to flagship

CDC surveillance systems 

Stronger workforce in data science, 

analytics, modeling, and informatics 

Targeted real-time communication

of data and results 

Real-time, linked systems that 

recognize threats early to inform 

timely response 

A highly skilled workforce that

applies state-of-the-art data skills

and tools 

High-quality information and

guidance to protect people’s health 

Every American has

equal opportunity to attain 

the highest level of

health possible

All people have the right

 information at the right time

to make decisions

SUPPORT STRATEGIC 

INNOVATION

Seek partner-driven data solutions 

Develop next-generation tools

(e.g., modeling, visualization,

predictive analysis, machine learning)

Strengthen predictive analytics

and forecasting

Integration and use of data from new

or non-traditional sources

Improved pathways to explore,

develop, and deploy next-generation 

technologies 

Quick, continued data analysis with

adjustment of modeling in real time

Open-source, enterprise-level

technologies and coordinated 

systems 

New approaches to address present 

and future threats Our country is better

prepared for, and protected

from, all types of public

health threats

318212-A
(1) Adjusting Price $18.13 CWT

(2) Base Price $16.38 CWT

(3) Change from Base Price per CWT $1.75

(4) Price change per gallon $0.1505

(Line (3) divide by 11.63 gallons/cwt)

(5) Price change per half gallon $0.0752

Price change per quart $0.0376

Price change per pint $0.0188

Price change per 12-oz pg. $0.0141

Price change per 1/3 qt. (10-oz) $0.0118

Price change per half pint $0.0094

(6) Price adjustment per gallon $0.15

Price adjustment per half gallon $0.08

Price adjustment per quart $0.04

Price adjustment per pint $0.02

Price change per 12-oz pg. $0.01

Price adjustment per 1/3 qt. (10-oz) $0.01

Price adjustment per half pint $0.01

NOTE: Numbers in brackets are negative or decreases, all others are positive or increases.

Monthly EPA Calculation for Class I Milk (Clause 52.216-9032 Alt. I)

Based on California Dept. of Food and Agriculture Announcement of Minimum Prices

 Effective Date: Sept. 4, 2016
Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


AdultVaxView


Section Navigation
			
			CDC Home








Vaccination Coverage among Pregnant Women										Related Pages
										AdultVaxView
User Quick Guide | Download Data Table | Back to AdultVaxView main page
							
					
							Last Reviewed:  May 14, 2021						Source: 
	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeAdultVaxView Home
AdultVaxView Interactive!plus icon
General Population
Nursing Home
Pregnant Women
Publications and Resources
Data Sources
Objectives, Targets, and Indicators
For Specific Groupsplus icon
Adults
College and Technical School Students
Healthcare Professionals
Pregnant Women
Media


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue
img142519850_0.jpg













Annual Statement as to Compliance

For the Year Ended December 31, 2022



|                                              
|----------------------------------------------
|Citigroup Commercial Mortgage Securities Inc.,
|Series 2017-CD5                               



Pursuant to Section 3.01 (37) of the Subservicing Agreement governing the referenced transaction (the “Servicing Agreement”), I hereby attest that:



i. A review of the activities and performance of Berkadia as Subservicer during the period has been made under my supervision.




ii. To the best of my knowledge, based on such review, Berkadia as Subservicer has fulfilled, in all material respects, its obligations under this Subservicing Agreement throughout the period and no default by the Subservicer under the Subservicing Agreement has occurred and is continuing.




Berkadia,



/s/ Mark E. McCool



Mark E. McCool

President

February 10, 2023









Inv. 228 Lib. A

---
[Federal Register Volume 63, Number 138 (Monday, July 20, 1998)]
[Notices]
[Page 38825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19230]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. ER98-3487-000]


PJM Interconnection, L.L.C.; Notice of Filing

July 14, 1998.
    Take notice that on June 24, 1998, the PJM Interconnection, L.L.C. 
(PJM), filed on behalf of the Members of the LLC, membership 
application of Statoil Energy Services, Inc. PJM requests an effective 
date on the date after this Notice of Filing is received by FERC.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 888 First Street, N.E., Washington, D.C. 20426, 
in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such 
motions and protests should be filed on or before July 24, 1998. 
Protests will be considered by the Commission to determine the 
appropriate action to be taken, but will not serve to make protestants 
parties to the proceedings. Any person wishing to become a party must 
file a motion to intervene. Copies of this filing are on file with the 
Commission and are available for public inspection.
Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 98-19230 Filed 7-17-98; 8:45 am]
BILLING CODE 6717-01-M
No. 11-211.

#### Live Gold Operations, Inc., Petitioner v. Paula T. Dow, Attorney General of New Jersey.

565 U.S. 977, 132 S. Ct. 500,

181 L. Ed. 2d 347,

2011 U.S. LEXIS 7810.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.

Same case below, 650 F.3d 223.
Chromium Metal Offering

Item # Location Drums Origin

Unit of Measure................... Pounds Cutoff Time for Receipt.........

February 7, 2022

February 8, 2022 

12:00pm

FISCAL YEAR 2022

Basic Ordering Agreement... Chromium Metal Date of Posting...................

Commodity.................................Chromium Metal Date for Receipt of Quotes....

Type Lot # Quantity Offered/Minimum Bid

Totals

Net Weight ST

NOTE: Minimum bid is one entire line item.

*

All quotes must be submitted through the DLA-Strategic Materials Sales Portal

and quoters must be pre-approved in the site to participate

DLA - Strategic Materials Sales Portal

145.9 ST 291,804 LBs

0274a Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.74 ST 13,477 LBs

0274b Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.74 ST 13,481 LBs

0274c Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.74 ST 13,477 LBs

0274d Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.75 ST 13,496 LBs

0274e Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.73 ST 13,469 LBs

0276a Aluminothermic HAMMOND, IN 018 20 UNITED KINGDOM 6.74 ST 13483 LBs

0276b Aluminothermic HAMMOND, IN 018 16 UNITED KINGDOM 5.39 ST 10774 LBs

0348a Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0348b Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0348c Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0348d Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0375a Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0375b Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.01 ST 20020 LBs

0399a Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 10.13 ST 20250 LBs

0399b Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 9.97 ST 19949 LBs

0399c Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 9.96 ST 19914 LBs

0399d Electrolytic HAMMOND, IN 14-A 28 DOMESTIC 9.96 ST 19914 LBs
P. 1 

# OAR Box 

# 1875 Prepped byOllie Stewart



## Document

Number: 

# 15 ) ll-E-3 3 Docket Number: 

# A-90-1 9

Printed 12/1/200811:12:44

AM Sheet 15of 86P. 2

• I i > i ,—-—•• > * I I 

# JAC ACorp . DE

C 1 8 199 2 / A-90-1 9

ll-E-3 3 \ P:. : 

### \; f 

### r"•- - 55 0 Pinetown Rd .

! . \ Ft . Washington , P A1903 4 \i.„ 215/643-5466 Fax : 215/643-277 2

- '



### Projec tName : Perso n Contacted/Tit I Phon e Numbe i | Compan y | Representing : JACARepresentativ

e Discussion : 

# * Telephone Lo g v^ r^^ ri^:;&

f

HO N 

### e : 1 1-800-321-824 2 Th e C . P . Hal l Co . : Christophe rHolme s I calle d C . P . Hal l fo r Date : Februar y26 . 199 2 

### Time : Proiec tNo. : 01430

8
Fax :

Dric e Quote s fo rdiisooctv l Phthalate . Th e followin aDrice s wer e aiven : QUANTIT

Y 1- 2 44 0 lb . drum s 3- 9 44 0 lb . drum s 10-2 4 44 0 lb . drum s 4 0 ,00 0 lb . minimu m PRIC E .82/l b .79/l b .77/l b .52/1 b